Current therapeutic paradigm in pediatric atopic dermatitis: Practical guidance from a national expert panel.

Adrenal Cortex Hormones / therapeutic use Adult Calcineurin Inhibitors / therapeutic use Child Consensus Dermatitis, Atopic / therapy Emollients / therapeutic use Expert Testimony Humans Practice Guidelines as Topic
Atopic dermatitis Atopy Management Probiotics Therapy

Journal

Allergologia et immunopathologia
ISSN: 1578-1267
Titre abrégé: Allergol Immunopathol (Madr)
Pays: Singapore
ID NLM: 0370073

Informations de publication

Date de publication:
Historique:
received: 10 05 2018
accepted: 13 06 2018
pubmed: 1 10 2018
medline: 27 6 2019
entrez: 1 10 2018
Statut: ppublish

Résumé

Atopic dermatitis (AD) is the most common cutaneous inflammatory disease in both adults and children. Although emerging therapeutic approaches are being investigated for the management of pediatric AD, it still needs to be managed with conventional treatments. This consensus document is aimed at providing an update on general management and therapies of pediatric AD, defining practical recommendations for using both topical and systemic agents. A panel of experts consisting of dermatologists and pediatricians were convened in order to define statements, through a Delphi process, standardizing the management of AD in pediatric subjects in a real-world setting. A set of practical recommendations obtaining an at least 75% agreement was presented. This set of practical recommendations represents a simple and fast snapshot on the pediatric use of common anti-AD therapeutics.

Identifiants

DOI: 10.1016/j.aller.2018.06.008 PMID: 30268381
pubmed: 30268381
pii: S0301-0546(18)30119-8
doi: 10.1016/j.aller.2018.06.008
pii:
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Calcineurin Inhibitors 0
Emollients 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-206

Informations de copyright

Copyright © 2018 SEICAP. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

A Chiricozzi (A)

Dermatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy. Electronic address: chiricozziandrea@gmail.com.

A Belloni Fortina (A)

Pediatric Dermatology Unit, Department of Medicine, University of Padua, Via Gallucci 4, 35128 Padua, Italy.

E Galli (E)

Pediatric Allergy Unit, Research Center, San Pietro Hospital - Fatebenefratelli, Via Cassia 600, 00189 Rome, Italy.

G Girolomoni (G)

Section of Dermatology and Venereology, Department of Medicine, University of Verona, Via dell'Artigliere 8, 37129 Verona, Italy.

I Neri (I)

Dermatology Unit, Department of Specialized, Diagnostic and Experimental Medicine, University of Bologna, Via Masserenti 1, 40138 Bologna, Italy.

G Ricci (G)

Pediatric Unit - Department of Medical and Surgical Sciences, S. Orsola Malpighi Hospital, University of Bologna, Pad. 16, Via Massarenti, 11 - 40138, Bologna, Italy.

M Romanelli (M)

Dermatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy.

D Peroni (D)

Pediatric Unit, Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56126 Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Hormones corticosurrénaliennes › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Mécanismes moléculaires de l'action pharmacologique › Antienzymes › Inhibiteurs de la calcineurine › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Personnes › Tranches d'âge › Enfant › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Maladies du système immunitaire › Hypersensibilité › Hypersensibilité immédiate › Eczéma atopique › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Produits dermatologiques › Émollient › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Organisations et économie des soins de santé › Contrôle social formel › Jurisprudence › Expertise › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Current therapeutic paradigm in pediatric...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Assurance de la qualité des soins de santé › Recommandations comme sujet › Guides de bonnes pratiques cliniques comme sujet › Current therapeutic paradigm in pediatric...